Experimental Alzheimer’s Drug Potential ‘Game Changer’ In Fight Against Disease
Scientists say they are cautiously optimistic with results from a trial of the new drug, which targets the dangerous plaques that build up in the brain -- a hallmark of Alzheimer's.
Los Angeles Times:
Experimental Drug Reduces Protein Clumps And Slows Memory Loss In Early Alzheimer's
In the search for a treatment capable of changing the course of Alzheimer’s disease, new findings are offering a rare glimmer of hope: In a preliminary trial of subjects suffering from memory and thinking problems or diagnosed with early Alzheimer’s, a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins — a hallmark of Alzheimer’s — from the brain. And compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function. (Healy, 8/31)